| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |